INDBInternet News Database 2.5 Updated 2 min ago · 288 sources Show or hide images Light or dark

Ruxolitinib Cream Well Tolerated in Children With AD

1 source1 article First seen Updated United States Truth score 38

Save Like Comments Compare coverage

Summary

Ruxolitinib cream used for 44 weeks keeps atopic dermatitis under control in children with no new safety signals, a phase 3 study finds.

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    Ruxolitinib Cream Well Tolerated in Children With AD

    Ruxolitinib cream used for 44 weeks keeps atopic dermatitis under control in children with no new safety signals, a phase 3 study finds.

Comments

Comments need JavaScript.